Showing 421 - 440 results of 27,284 for search '(( 50 ((ng decrease) OR (we decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.85s Refine Results
  1. 421

    Factors affecting the biology of <i>Pachycrepoideus vindemmiae</i> (Hymenoptera: Pteromalidae), a parasitoid of spotted-wing drosophila (<i>Drosophila suzukii</i>) by Cherre S. Bezerra Da Silva (7026926)

    Published 2019
    “…Based on survival and host-killing capacity, we conclude that <i>P</i>. <i>vindemmiae</i> has a tremendous biocontrol potential against SWD. …”
  2. 422

    Top 50 results of a commercial kinase screen using [γ<sup>33</sup>]-ATP and human obscurin SH3-DH as substrates. by Daniel Koch (388049)

    Published 2023
    “…While MST2 addition resulted in strong and saturable phosphorylation, TBK1 led to much lower phosphorylation levels and CaMK4 addition led to an intermediate phosphorylation level exhibiting a biphasic behaviour with phosphorylation levels decreasing at higher substrate concentrations. …”
  3. 423

    Species that significantly increased (“Winners”) or decreased (“Losers”) in abundance over the past 50+ years in the study area [33]. by Katie Frerker (680803)

    Published 2014
    “…</p><p>Species that significantly increased (“Winners”) or decreased (“Losers”) in abundance over the past 50+ years in the study area <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0115843#pone.0115843-Wiegmann1" target="_blank">[33]</a>.…”
  4. 424
  5. 425
  6. 426
  7. 427

    Anti-cancer stem cell activity of a sesquiterpene lactone isolated from <i>Ambrosia arborescens</i> and of a synthetic derivative by Wendy Soria Sotillo (4408105)

    Published 2017
    “…<div><p>New regimens are constantly being pursued in cancer treatment, especially in the context of treatment-resistant cancer stem cells (CSCs) that are assumed to be involved in cancer recurrence. Here, we investigated the anti-cancer activity of sesquiterpene lactones (SLs) isolated from <i>Ambrosia arborescens</i> and of synthetic derivatives in breast cancer cell lines, with a specific focus on activity against CSCs. …”
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433
  14. 434
  15. 435
  16. 436
  17. 437
  18. 438
  19. 439
  20. 440